Project description DEENESFRITPL Novel quality control technology boosts the capability of pharmaceutical capsule-filling machines Consumers expect that the medicines they take contain the exact dosage of active ingredients as labelled. Current capsule-filling machines are nearing their limits in terms of accuracy and quality monitoring, while regulatory agencies are becoming ever more stringent in this regard. The Italian SME MG2, in collaboration with its pharmaceutical industry customers, has developed TECHNOCAP, an innovative technology for existing capsule-filling machines to guarantee optimum end product weight/filling while enabling real-time continuous data collection, analysis and interpretation for quality control. The EU-funded TechnocaP project will support the company in optimising its technical and commercial strategies. Show the project objective Hide the project objective Objective TECHNOCAP project is based on the industrialisation and commercialisation of a cutting-edge technology for capsule filling machines capable to significantly improve productivity, flexibility and quality of production for pharmaceutical companies. The pioneer of this disruptive project is MG2 S.r.l. industrial company specialized in the design, manufacturing and marketing of automatic machines for pharmaceuticals.Capsules are the most versatile of all dosage forms, in which one or more medicinal and inert ingredients are enclosed in a small shell or container usually made of gelatine. Nowadays, the regulatory authorities (EMA, FDA) are increasing exponentially their demand in terms of quality and dosage accuracy of the finished product. In fact, current technological solutions are reaching their limits, directly affecting the small, medium and large size pharmaceutical companies and their derived supply chain (i.e. pharmacies and consumer patients).Working in close collaboration with our customers in the pharmaceutical sector to response to inefficient methods present in the market, MG2 conceives TECHNOCAP, an innovative technology for capsule filling machines to boost the pharmaceutical manufacturing process. This technolog is able, under production rate, to control 100% of the weight/presence of all filled capsules to guarantee optimum end product quality, while enabling in real-time continuous data collection, analysis and interpretation to be used in production and quality control activities. As this project addresses MG2 commercial and technical strategies, we strongly believe that it will contribute to boost the growth of our company achieving, after 5 years of exploitation, 11% of market penetration, 28M€ of accumulated gross profit translated into a ROI ≥ 8.18 (with 70 sold machines) and a company growth of 55 new people. Fields of science engineering and technologymechanical engineeringmanufacturing engineeringmedical and health sciencesbasic medicinepharmacology and pharmacypharmaceutical drugssocial scienceseconomics and businesseconomicsproduction economicsproductivity Programme(s) H2020-EU.2.1.2. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Nanotechnologies Main Programme H2020-EU.2.1.5. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Advanced manufacturing and processing H2020-EU.2.1.3. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Advanced materials H2020-EU.2.3.1. - Mainstreaming SME support, especially through a dedicated instrument Topic(s) SMEInst-02-2016-2017 - Accelerating the uptake of nanotechnologies advanced materials or advanced manufacturing and processing technologies by SMEs Call for proposal H2020-SMEInst-2016-2017 See other projects for this call Sub call H2020-SMEINST-1-2016-2017 Funding Scheme SME-1 - SME instrument phase 1 Coordinator MG2 - SRL Net EU contribution € 50 000,00 Address Via del savena 18 40065 Pianoro Italy See on map Region Nord-Est Emilia-Romagna Bologna Activity type Private for-profit entities (excluding Higher or Secondary Education Establishments) Links Contact the organisation Opens in new window Participation in EU R&I programmes Opens in new window HORIZON collaboration network Opens in new window Other funding € 21 429,00
